Abstract
A group of antiparkinson drugs (benactyzine, biperiden, caramiphen, procyclidine, and trihexyphenidyl) has been shown to possess both anticholinergic and antiglutamatergic properties, making these agents very well suited as anticonvulsants against nerve agents. The first purpose of this study was to make a comparative assessment of the anticonvulsant potencies of the antiparkinson agents when microinfused (1 μl) into the seizure controlling area tempestas (AT) of rats 20 min before subcutaneous injection of soman (100 μg/kg). The second purpose was to determine whether cholinergic and/or glutamatergic antagonism was the effective property. The results showed that only procyclidine (6 μg) and caramiphen (10 μg) antagonized soman-induced seizures. Cholinergic, and not glutamatergic, antagonism was likely the active property, since atropine (100 μg), and scopolamine (1 μg) caused anticonvulsant effects, whereas MK-801 (1 μg), and ketamine (50 μg) did not. Soman (11 nmol) injected into AT resulted more frequently in clonic convulsions than full tonic–clonic convulsions. AT may serve as both a trigger site for soman-evoked seizures and a site for screening anticonvulsant potencies of future countermeasures.
Similar content being viewed by others
References
McDonough JH Jr, Shih T-M (1997) Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21:559–579
Myhrer T, Skymoen LR, Aas P (2003) Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats. Neurotoxicology 24:357–367
Myhrer T, Nguyen NHT, Enger S, Aas P (2006) Anticonvulsant effects of GABAA modulators microinfused into area tempestas or substantia nigra in rats exposed to soman. Arch Toxicol 80:502–507
Myhrer T, Nguyen NHT, Andersen JM, Aas P (2004) Protection against soman-induced seizures: relationship among doses of prophylactics, soman, and adjuncts. Toxicol Appl Pharmacol 196:327–336
Jouver P, Pain L, Aunis D, Zwiller J (2002) The anesthetics propofol and ketamine inhibit cocain-induced egr-1 gene expression in rat forebrain. Eur J Pharmacol 449:239–243
Sanna E, Mascia MP, Klein RL, Whiting PJ, Biggio G, Harris RA (1995) Actions of the general anesthetic propofol on recombinant human GABAA receptors: influence on receptor subunits. J Pharmacol Exp Ther 274:353–360
Gao ZG, Liu BY, Cui WY, Li LJ, Fan QH, Liu CG (1998) Anti-nicotonic properties of anticholinergic antiparkinson drugs. J Pharm Pharmacol 50:1299–1305
McDonough JH Jr, Shih T-M (1995) A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol Biochem Behav 51:249–253
Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R (2002) Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23:7–17
Gale K (1988) Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia 29(Suppl 2):S15–S34
Löscher W, Ebert U (1996) Basic mechanism of seizure propagation: targets for rational drug design and rational polypharmacy. Epilepsy Res Suppl 11:17–43
Ekstrand JJ, Domroese ME, Johnson DMG, Feig SL, Knodel SM, Behan M, Haberly LB (2001) A new subdivision of anterior piriform cortex and associated deep nucleus with novel features of interest for olfaction and epilepsy. J Comp Neurol 434:289–307
Piredda S, Gale K (1985) A crucial epileptogenic site in the deep prepiriform cortex. Nature 317:623–625
Myhrer T, Enger S, Aas P (2006) Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. Basic Clin Pharmacol Toxicol 98:184–191
Braitman DJ, Sparenborg S (1989) MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res Bull 23:145–148
Shih T-M, Koviak TA, Capacio BR (1991) Anticonvulsants for poisoning by the organophosphorous compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 15:349–362
Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123–130
Capacio BR, Shih T-M (1991) Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia 32:604–615
McDonough JH Jr, McLeod CG Jr, Nipwoda T (1987) Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res 435:123–137
Lallement G, Denoyer M, Collet A, Pernot-Marino I, Baubichon D, Monmaur P, Blanchet G (1992) Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures; influence of septal cholinoceptive cells. Neurosci Lett 139:104–107
McDonough JH Jr, Shih T-M (1993) Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev 17:203–215
Shih T-M, McDonough JH Jr, Koplovitz I (1999) Anticonvulsants for soman-induced seizure activity. J Biomed Sci 6:86–96
Myhrer T, Andersen JM (2001) Interference with visual memory in rats following infusion of the functional NMDA receptor antagonist, HA-966, into temporal regions. Eur J Pharmacol 428:323–330
Øydvin OK, Tansø R, Aas P (2005) Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication. Eur J Pharmacol 516:227–234
Harris LW, McDonough JH Jr, Stitcher DL, Lennox WJ (1984) Protection against both lethal and behavioral effects of soman. Drug Chem Toxicol 7:605–624
Kumari M, Ticku MK (2000) Regulation of NMDA receptors by ethanol. Progr Drug Res 54:152–189
McDonough JH, Shih T-M, Adams N (1993) Forebrain areas sensitive to the convulsant effects of the anticholinesterase agent VX. Neurosci Abs 19:1630
Zimmer LA, Ennis M, Wiley RG, Shipley MT (1998) Nerve gas-induced seizures: role of acetylcholine in the rapid inductions of Fos and glial fibrillary acidic protein in piriform cortex. J Neurosci 15:3897–3908
Browning RA, Nelson DK (1986) Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 93:546–556
Hudkins RL, Stubbins JF, DeHaven-Hudkins DL (1993) Caramiphen, iodocaramiphen and nitrocaramiphen are potent, competitive, muscarinic M1 receptor-selective agents. Eur J Pharmacol 231:485–488
Waelbroeck M, Camus J, Tastenoy M, Lambrecht G, Mutschler ETR, Christophe J (1990) Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M1, M2 and M4. Eur J Pharmacol 189:135–142
Reynolds IJ, Miller RJ (1988) [3H]MK-801 binding to the N-methyl-D-aspartate receptor reveals drug interaction with the zinc and magnesium biding sites. J Pharmacol Exp Ther 247:1025–1031
Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA (1999) The involvement of NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology 20:551–560
Raveh L, Brandeis R, Gilat E, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Weissman BA (2003) Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. Toxicol Sci 75:108–116
Bajgar J (2004) Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216
Kassa J, Krejcova G, Samnaliev I (2003) A comparison of neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats. Acta Med (Hradec Kralove) 46:101–107
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue article in honor of Dr. Frode Fonnum.
Rights and permissions
About this article
Cite this article
Myhrer, T., Enger, S. & Aas, P. Anticonvulsant Efficacy of Drugs with Cholinergic and/or Glutamatergic Antagonism Microinfused into Area Tempestas of Rats Exposed to Soman. Neurochem Res 33, 348–354 (2008). https://doi.org/10.1007/s11064-007-9429-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9429-3